The National Health Service (NHS) in Wales has announced that it will be the first in the UK to distribute a cannabis-based medicine for the treatment of multiple sclerosis (MS). According to the NHS, Sativex, a cannabis-based medicine made of one part THC (tetrahydrocannabinol) and one part CBD (cannabidiol), will be available by prescription for …
- Medical Cannabis Use Associated With Reduced Opioid Use In Pain Patients, Finds Study
- Study: Marijuana Stores Associated With Increased Home Values
- U.S. Congress Approves Bill to Legalize Hemp, Sending it to President Trump
- New Zealand Parliament Approves Medical Marijuana Legislation
- California Officials Say Cannabis Deliveries Can Be Made Anywhere, Even in Cities Where Marijuana is Banned
- U.S. Surgeon General Says We Need to Reconsider How We Schedule Marijuana
- Study: CBD Reduces Airway Inflammation and Fibrosis in Experimental Allergic Asthma.
- Marijuana and Marijuana Concentrates Become Legal in Michigan on December 6
Thank you for reading TheJointBlog.com!